HUMAPEN LUXURA Trademark

Trademark Overview

On Thursday, February 17, 2005, a trademark application was filed for HUMAPEN LUXURA with the United States Patent and Trademark Office. The USPTO has given the HUMAPEN LUXURA trademark a serial number of 78569420. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, September 27, 2017. This trademark is owned by Eli Lilly and Company. The HUMAPEN LUXURA trademark is filed in the Medical Instrument Products category with the following description:

Insulin delivery devices, namely, syringes
humapen luxura

General Information

Serial Number78569420
Word MarkHUMAPEN LUXURA
Filing DateThursday, February 17, 2005
Status800 - REGISTERED AND RENEWED
Status DateWednesday, September 27, 2017
Registration Number3308394
Registration DateTuesday, October 9, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2005

Trademark Statements

Goods and ServicesInsulin delivery devices, namely, syringes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, February 28, 2005
Primary Code010
First Use Anywhere DateMonday, March 26, 2007
First Use In Commerce DateMonday, March 26, 2007

Trademark Owner History

Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Wednesday, September 27, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, September 27, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, September 27, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 27, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 22, 2017TEAS SECTION 8 & 9 RECEIVED
Sunday, October 9, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, September 26, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, September 26, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, September 11, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Friday, September 20, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 11, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 9, 2007REGISTERED-PRINCIPAL REGISTER
Saturday, September 1, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, September 1, 2007ASSIGNED TO LIE
Tuesday, July 24, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, June 30, 2007STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 28, 2007USE AMENDMENT FILED
Thursday, June 28, 2007TEAS STATEMENT OF USE RECEIVED
Friday, June 15, 2007EXTENSION 2 GRANTED
Tuesday, March 13, 2007EXTENSION 2 FILED
Tuesday, March 13, 2007TEAS EXTENSION RECEIVED
Thursday, August 10, 2006EXTENSION 1 GRANTED
Thursday, August 10, 2006EXTENSION 1 FILED
Thursday, August 10, 2006TEAS EXTENSION RECEIVED
Tuesday, March 21, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 27, 2005PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2005NOTICE OF PUBLICATION
Thursday, November 10, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 9, 2005ASSIGNED TO LIE
Thursday, November 3, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 20, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 5, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 5, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 18, 2005NON-FINAL ACTION E-MAILED
Sunday, September 18, 2005NON-FINAL ACTION WRITTEN
Wednesday, September 14, 2005ASSIGNED TO EXAMINER
Monday, February 28, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

luxura humapen syringes namely devices delivery insulin